Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Michael Okun

Movement Disorders · UF

View

Dr. Jonathan Rosand

Neurocritical Care · Broad Institute

View

Dr. Jinsy Andrews

ALS · NYU Langone

View

Dr. Maisha Robinson

Hospice & Palliative Care · Mayo Clinic Florida

View

Dr. Michael Kentris

Epilepsy · St. Elizabeth Medical Center

View

Dr. Daniel Correa

Epilepsy · AECOM

View

Dr. Aaron Berkowitz

General Neurology · UCSF

View

Dr. Jose Hernan Posas

Sports Neurology · UVA

View

Dr. Joseph Sirven

Epilepsy · Mayo Clinic College of Medicine

View

Dr. Rachel Marie Salas

Sleep Medicine · Johns Hopkins

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    CTDr. Caroline Tanner

    Dr. Caroline Tanner

    Neurology · Movement Disorders
    University of San Francisco California
    carolinet

    Research

    Clinical and Imaging Characteristics of Parkinson's Disease with Negative Alpha-Synuclein Seed Amplification Assay

    2026

    Via Movement Disorders

    Research

    Feasibility for a Community-Based Parkinson Disease Cohort in Hawaii

    2026

    Via Neurology: Clinical Practice

    Research

    Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMI

    2026

    Via Annals of Neurology

    Research

    Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined Synucleinopathy

    2026

    Via Annals of Clinical and Translational Neurology

    Research

    How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early-Stage Neuronal Alpha-Synuclein Disease

    2026

    Via Annals of Neurology

    Research

    Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI

    2026

    Via Annals of Neurology

    Research

    Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease

    2026

    Via Annals of Neurology

    Research

    Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative

    2026

    Via Annals of Neurology

    Research

    Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial

    2025

    Via Neuropsychopharmacology

    Research

    Neuronal α-Synuclein Disease Stage Progression over 5 Years

    2025

    Via Movement Disorders

    Research

    Stable two-year longitudinal clinical outcomes in LRRK2 G2019S non-manifest carriers in a remote nationwide study

    2025

    Via Parkinsonism & Related Disorders

    Research

    Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational Study (AT-HOME PD2)

    2025

    Via JMIR Research Protocols

    Research

    Trichloroethylene and Parkinson Disease

    2025

    Via Neurology

    Research

    Environmental toxicants and Parkinson's disease: recent evidence, risks, and prevention opportunities

    2025

    Via The Lancet Neurology

    Research

    Self-perceived life course sleep duration trajectories and risk and age at onset of Parkinson's disease

    2025

    Via NPJ Parkinson's Disease